5.jpg
3.jpg
2.jpg
1.jpg
4.jpg

Patient Benefits

Print PDF

Sodium chloride aerosol improves rheological properties of bronchial contents, decreases edema of bronchial mucosa and contributes to the functioning of cilia epithelium. It has a bactericidal action and enhances the activity of alveolar macrophages. *

In addition, Halotherapy provides a host of benefits.  Some of the major clinical findings are as follows:

  • Reduced bronchial hyper-responsiveness as an add-on therapy in asthmatics with low to moder­ate doses of inhaled steroids.***
  • Relieved cough, improved sputum properties, improved auscultative findings and functional pa­rameters. Inhalation of the DSCA (dry sodium chloride  aerosol) characterized by fixed density and low doses of sodium chloride, rendered sanitary action in the respiratory tract and it was noted that the therapy could be used for primary prevention of COPD.**
  • The number and intensity of asthma attacks was reduced and respiratory discomfort decreased or disappeared, which allowed in a number of cases the reduction or elimination of prescribed beta­-agonists.*
  • Better drain function of patients' airways was observed along with alleviation of sputum secre­tion, decrease in viscosity, relief from coughs and improvement of the auscultative picture of the lungs.*
  • Positive influence on bronchial obstruction was noted.*
  • Improvement of mucociliary clearance and decrease of bronchial inflammation was evident*
  • Average amount of neutrophils, macrophages and lymphocytes was diminished.*
  • There was a decrease in the amount of neutrophils and pathogenic microorganisms and an in­crease in the amount of alveolar macrophages in bronchial secretion of patients with BA, chronic obstructive bronchitis and cystic fibrosis after HT (Voronina at al, 1994)*
  • Elimination of pathogenic microorganisms and a decrease in inflammatory reaction of the mu­cosa was observed.*
  • Research confirmed the positive effects of HT on the state of humoral and cellular immunity in patients with BA (Spesivykh et al, 1990, Torokhtin et al, 1987); decrease of IgE level was observed.  (Dityatkovskaya et al, 1993).*
  • Contributed bactericidal and bacteriostatic effects on the respiratory airways microflora and showed prevention of the development of inflammatory processes (Simyonka, 1989, Rein & Mandell, 1973).*
  • Low doses of DSCA had a beneficial effect on phagocytic activity of alveolar macrophages (Konovalov et al, 1992) and thus on bronchial clearance and elimination of foreign agents.*

In summary, theoretical prerequisites and the data collected during clinical studies suggest the ef­ficacy of HT results from the combination of the curative properties of dry sodium chloride aerosol and the method of its administration.*


*Chervinskaya AV, Zilber NA. Halotherapy for treatment of respiratory diseases. J Aerosol Med 1995:8(3):221-232.
** Chervinskaya AV. Respiratory hygiene with dry sodium chloride aerosol. 14th Annual Congress of the Respiratory Society, Glasgow, September 2004. Session "Clinical and physiological observations from health to chronic illness", Poster P2514 *** J. Hedman, T. Hugg, J. Sandell, T. Haahtela. The effect of salt chamber treatment on bronchial hyperresponsiveness in asthmatics. Allergy 2006: 61: 605-610